These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31214874)

  • 1. Relative hypophosphatemia early after transplantation is a predictor of good kidney graft function.
    Nakai K; Mitsuiki K; Kuroki Y; Nishiki T; Motoyama K; Nakano T; Kitazono T
    Clin Exp Nephrol; 2019 Sep; 23(9):1161-1168. PubMed ID: 31214874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
    Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
    Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.
    van Londen M; Aarts BM; Deetman PE; van der Weijden J; Eisenga MF; Navis G; Bakker SJL; de Borst MH;
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1301-1310. PubMed ID: 28546442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
    Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
    Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum Phosphorus Concentration with Mortality and Graft Failure among Kidney Transplant Recipients.
    Jeon HJ; Kim YC; Park S; Kim CT; Ha J; Han DJ; Oh J; Lim CS; Jung IM; Ahn C; Kim YS; Lee JP; Kim YH
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):653-662. PubMed ID: 28159828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
    Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
    Am J Transplant; 2007 May; 7(5):1193-200. PubMed ID: 17359508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.
    Kanaan N; Claes K; Devogelaer JP; Vanderschueren D; Depresseux G; Goffin E; Evenepoel P
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1887-92. PubMed ID: 20634326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.
    Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM
    Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum phosphate measured at 6 and 12 months after successful kidney transplant is independently associated with subsequent graft loss.
    Benavente D; Chue CD; Moore J; Addison C; Borrows R; Ferro CJ
    Exp Clin Transplant; 2012 Apr; 10(2):119-24. PubMed ID: 22432754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Ando K; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Ther Apher Dial; 2011 Oct; 15(5):481-7. PubMed ID: 21974702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal phosphate loss in long-term kidney transplantation.
    Sirilak S; Chatsrisak K; Ingsathit A; Kantachuvesiri S; Sumethkul V; Stitchantrakul W; Radinahamed P; Disthabanchong S
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):323-31. PubMed ID: 22134626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia.
    Green J; Debby H; Lederer E; Levi M; Zajicek HK; Bick T
    Kidney Int; 2001 Sep; 60(3):1182-96. PubMed ID: 11532115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.
    Bleskestad IH; Bergrem H; Leivestad T; Hartmann A; Gøransson LG
    Clin Transplant; 2014 Apr; 28(4):479-86. PubMed ID: 25649861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
    Oh IH; Lee CH; Kim GH; Kang CM; Park JS
    Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercial kidney transplantation is an important risk factor in long-term kidney allograft survival.
    Prasad GVR; Ananth S; Palepu S; Huang M; Nash MM; Zaltzman JS
    Kidney Int; 2016 May; 89(5):1119-1124. PubMed ID: 27083285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and long-term outcomes of post-transplant hypophosphatemia after kidney transplantation.
    Huber L; Naik M; Budde K
    Transpl Int; 2013 Oct; 26(10):e94-6. PubMed ID: 23937423
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of monocyte-macrophage inhibition by ibandronate on graft function and survival after kidney transplantation: a single-centre follow-up study over 15 years.
    Tillmann FP; Grotz W; Rump LC; Pisarski P
    Clin Exp Nephrol; 2018 Apr; 22(2):474-480. PubMed ID: 28856476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.